Skip to main content
Erschienen in: Surgical Endoscopy 7/2007

01.07.2007

Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients

verfasst von: J. J. Rasmussen, W. Fuller, M. R. Ali

Erschienen in: Surgical Endoscopy | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Marginal ulceration after Roux-en-Y gastric bypass (RYGB) is diagnosed in 1% to 16% of patients. The factors predisposing patients to marginal ulceration are still unclear.

Methods

A total of 260 patients who underwent laparoscopic RYGB were retrospectively reviewed. Data regarding demographics, comorbidities, body mass index (BMI), Helicobacter pylori infection, gastrojejunal (GJ) anastomotic leaks, postoperative bleeding, operative time, type of suture material, and marginal ulcer formation were collected. Fisher’s exact test was used for statistical analysis of discrete variables, and Student’s t-test was used for continuous variables. Statistical significance was set at an alpha of 0.05.

Results

The overall marginal ulceration rate was 7%. Demographic data (age, gender distribution, BMI) did not differ significantly between patients who experienced marginal ulceration and those who did not (p > 0.05). Similarly, technical factors (choice of permanent or absorbable suture for the GJ anastomosis, attending as primary surgeon, robotic GJ, operative time, postoperative hematocrit drop) were not statistically different between the two groups (p > 0.05). Finally, the prevalence of comorbidities (diabetes, hypertension, obstructive sleep apnea, musculoskeletal complaints, dyslipidemia, gastroesophageal reflux disease [GERD] and peptic ulcer disease [PUD]) did not differ significantly between the two groups (p > 0.05). However, preoperative H. pylori infection, although adequately treated, was twice as common among the patients who had marginal ulceration (32%) as among those who did not (12%) (p = 0.02). All the patients who experienced marginal ulcers had complete resolution of symptoms with proton pump inhibitors and sucralfate. No reoperations were required for marginal ulceration.

Conclusion

Helicobacter pylori may potentiate marginal ulcer formation. The authors hypothesize that H. pylori damages the mucosal barrier in a way that persists postoperatively, which may precipitate marginal ulceration even when the organism has been medically eradicated.
Literatur
1.
Zurück zum Zitat Ali MR, Fuller WD, Choi MP, Wolfe BM (2005) Bariatric surgical outcomes. Surg Clin North Am 4: 835–852CrossRef Ali MR, Fuller WD, Choi MP, Wolfe BM (2005) Bariatric surgical outcomes. Surg Clin North Am 4: 835–852CrossRef
2.
Zurück zum Zitat Behrns KE, Smith CD, Sarr MG (1994) Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci 39: 315–320PubMedCrossRef Behrns KE, Smith CD, Sarr MG (1994) Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci 39: 315–320PubMedCrossRef
3.
Zurück zum Zitat Ben-Meir A, Sonpal I, Patterson L, Schreiber H, Salomone M, Sharma K, Kumar A, Marshall JB (2005) Cigarette smoking, but not NSAID or alcohol use or comorbidities, is associated with anastomotic ulcers in Roux-en-Y gastric bypass (RYGB) patients. Surg Obes Relat Dis 1: 263CrossRef Ben-Meir A, Sonpal I, Patterson L, Schreiber H, Salomone M, Sharma K, Kumar A, Marshall JB (2005) Cigarette smoking, but not NSAID or alcohol use or comorbidities, is associated with anastomotic ulcers in Roux-en-Y gastric bypass (RYGB) patients. Surg Obes Relat Dis 1: 263CrossRef
4.
Zurück zum Zitat Capella JF, Capella RF (1996) Staple disruption and marginal ulceration in gastric bypass procedures for weight reduction. Obes Surg 6: 44–49PubMedCrossRef Capella JF, Capella RF (1996) Staple disruption and marginal ulceration in gastric bypass procedures for weight reduction. Obes Surg 6: 44–49PubMedCrossRef
5.
Zurück zum Zitat Capella JF, Capella RF (1999) Gastrogastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg 9: 22–27PubMedCrossRef Capella JF, Capella RF (1999) Gastrogastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg 9: 22–27PubMedCrossRef
6.
Zurück zum Zitat Capella JF, Capella RF (2002) An assessment of vertical banded gastroplasty–Roux-en-Y gastric bypass for the treatment of morbid obesity. Am J Surg 183: 117–123PubMedCrossRef Capella JF, Capella RF (2002) An assessment of vertical banded gastroplasty–Roux-en-Y gastric bypass for the treatment of morbid obesity. Am J Surg 183: 117–123PubMedCrossRef
7.
Zurück zum Zitat Cleator IGM (1996) Ulcerogenesis following gastric procedures for obesity. Obes Surg 6: 260–261PubMedCrossRef Cleator IGM (1996) Ulcerogenesis following gastric procedures for obesity. Obes Surg 6: 260–261PubMedCrossRef
8.
Zurück zum Zitat Cucchi SG, Pories WJ, MacDonald EK (1995) Gastrogastric fistulas: a complication of divided gastric bypass surgery. Ann Surg 221: 387–391PubMedCrossRef Cucchi SG, Pories WJ, MacDonald EK (1995) Gastrogastric fistulas: a complication of divided gastric bypass surgery. Ann Surg 221: 387–391PubMedCrossRef
9.
Zurück zum Zitat Dallal RM, Bailey LA (2006) Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis 2: 455–459PubMedCrossRef Dallal RM, Bailey LA (2006) Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis 2: 455–459PubMedCrossRef
10.
Zurück zum Zitat Fobi MAL (1992) Marginal ulcer after gastric bypass. In: Mason EE (ed) Surgical treatment of morbid obesity. problems in general surgery, vol 9, no 2, JB Lippincott, Philadelphia pp 345–352 Fobi MAL (1992) Marginal ulcer after gastric bypass. In: Mason EE (ed) Surgical treatment of morbid obesity. problems in general surgery, vol 9, no 2, JB Lippincott, Philadelphia pp 345–352
11.
Zurück zum Zitat Fobi MAL (1993) Operations that are questionable for control of obesity. Obes Surg 3: 197–200PubMedCrossRef Fobi MAL (1993) Operations that are questionable for control of obesity. Obes Surg 3: 197–200PubMedCrossRef
12.
Zurück zum Zitat Fobi MAL, Lee H, Igew D (2001) Prospective comparative evaluation of stapled versus transected Silastic ring gastric bypass: six-year follow-up. Obes Surg 1: 18–24CrossRef Fobi MAL, Lee H, Igew D (2001) Prospective comparative evaluation of stapled versus transected Silastic ring gastric bypass: six-year follow-up. Obes Surg 1: 18–24CrossRef
13.
Zurück zum Zitat Gisbert JP, Blanco M, Pajares JM (2000) Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa: an 18-month follow-up study. Rev Clin Esp 9: 480–484 Gisbert JP, Blanco M, Pajares JM (2000) Effect of Helicobacter pylori eradication on histological lesions of gastric mucosa: an 18-month follow-up study. Rev Clin Esp 9: 480–484
14.
Zurück zum Zitat Griffen WO (1997) Stomal ulcer after gastric restrictive operations. J Am Coll Surg 185: 87–88PubMedCrossRef Griffen WO (1997) Stomal ulcer after gastric restrictive operations. J Am Coll Surg 185: 87–88PubMedCrossRef
15.
Zurück zum Zitat Gumbs AA, Duffy AJ, Bell RL (2006) Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis 4: 460–463CrossRef Gumbs AA, Duffy AJ, Bell RL (2006) Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis 4: 460–463CrossRef
16.
Zurück zum Zitat Hedberg J, Hedenstrom H, Nilsson S, Sundbom M, Gustavsson S (2005) Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg 15: 1375–1378PubMedCrossRef Hedberg J, Hedenstrom H, Nilsson S, Sundbom M, Gustavsson S (2005) Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg 15: 1375–1378PubMedCrossRef
17.
Zurück zum Zitat Higa KD, Boone KB, Ho T (2000) Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients: what have we learned? Obes Surg 6: 509–513CrossRef Higa KD, Boone KB, Ho T (2000) Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients: what have we learned? Obes Surg 6: 509–513CrossRef
18.
Zurück zum Zitat Jordan JH, Hocking MP, Rout WR, Woodward ER (1991) Marginal ulcer following gastric bypass for morbid obesity. Am Surg 57: 286–288PubMed Jordan JH, Hocking MP, Rout WR, Woodward ER (1991) Marginal ulcer following gastric bypass for morbid obesity. Am Surg 57: 286–288PubMed
19.
Zurück zum Zitat Kral JG (1985) Morbid obesity and related health risks. Ann Intern Med 103: 1043–1047PubMed Kral JG (1985) Morbid obesity and related health risks. Ann Intern Med 103: 1043–1047PubMed
20.
Zurück zum Zitat Kyzekova J, Mour J (1999) The effect of eradication therapy on histological changes in the gastric mucosa in patients with nonulcer dyspepsia and Helicobacter pylori infection: prospective randomized intervention study. Hepatogastroenterology 46: 2048–2056PubMed Kyzekova J, Mour J (1999) The effect of eradication therapy on histological changes in the gastric mucosa in patients with nonulcer dyspepsia and Helicobacter pylori infection: prospective randomized intervention study. Hepatogastroenterology 46: 2048–2056PubMed
21.
Zurück zum Zitat MacLean LD, Rhode BM, Nohr C, Katz S, McLean AP (1997) Stomal ulcer after gastric bypass. J Am Coll Surg 185: 1–7PubMedCrossRef MacLean LD, Rhode BM, Nohr C, Katz S, McLean AP (1997) Stomal ulcer after gastric bypass. J Am Coll Surg 185: 1–7PubMedCrossRef
22.
Zurück zum Zitat Marano BJ (2005) Endoscopy after Roux-en-Y gastric bypass: a community hospital experience. Obes Surg 15: 342–345PubMed Marano BJ (2005) Endoscopy after Roux-en-Y gastric bypass: a community hospital experience. Obes Surg 15: 342–345PubMed
24.
Zurück zum Zitat Mason EE, Munns JR, Kealey GP (1976) Effect of gastric bypass on gastric secretion. Am J Surg 131: 162–168PubMedCrossRef Mason EE, Munns JR, Kealey GP (1976) Effect of gastric bypass on gastric secretion. Am J Surg 131: 162–168PubMedCrossRef
25.
Zurück zum Zitat National Institutes of Health (1991) Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 115: 956–961 National Institutes of Health (1991) Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 115: 956–961
26.
Zurück zum Zitat Pope GD, Goodney PP, Burchard KW (2002) Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg 12: 30–33PubMedCrossRef Pope GD, Goodney PP, Burchard KW (2002) Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg 12: 30–33PubMedCrossRef
27.
Zurück zum Zitat Printen KJ, Scott D, Mason EE (1980) Stomal ulcers after gastric bypass. Arch Surg 115: 525–527PubMed Printen KJ, Scott D, Mason EE (1980) Stomal ulcers after gastric bypass. Arch Surg 115: 525–527PubMed
28.
Zurück zum Zitat Rolls BJ (2003) The supersizing of America portion size and the obesity epidemic. Nutr Today 38: 42–53PubMedCrossRef Rolls BJ (2003) The supersizing of America portion size and the obesity epidemic. Nutr Today 38: 42–53PubMedCrossRef
29.
Zurück zum Zitat Sacks BC, Qureshi FG, Eid GM, Collins JL, Barinas-Mitchell EJ, Schauer PR, Ramanathan RC (2006) Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2: 11–16PubMedCrossRef Sacks BC, Qureshi FG, Eid GM, Collins JL, Barinas-Mitchell EJ, Schauer PR, Ramanathan RC (2006) Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2: 11–16PubMedCrossRef
30.
Zurück zum Zitat Sanyal AJ, Sugerman HJ, Kellum JM, Engle KM, Wolfe L (1992) Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol 87: 1165–1169PubMed Sanyal AJ, Sugerman HJ, Kellum JM, Engle KM, Wolfe L (1992) Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol 87: 1165–1169PubMed
31.
Zurück zum Zitat Sapala JA, Wood MH, Sapala MA, Flake Jr TM (1998) Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg 8: 505–516PubMedCrossRef Sapala JA, Wood MH, Sapala MA, Flake Jr TM (1998) Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg 8: 505–516PubMedCrossRef
32.
Zurück zum Zitat Schauer PR, Ikramuddin S (2001) Laparoscopic surgery for morbid obesity. Surg Clin North Am 81: 1145–1179PubMedCrossRef Schauer PR, Ikramuddin S (2001) Laparoscopic surgery for morbid obesity. Surg Clin North Am 81: 1145–1179PubMedCrossRef
33.
Zurück zum Zitat Schirmer B, Erenoglu C, Miller A (2002) Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg 12: 634–638PubMedCrossRef Schirmer B, Erenoglu C, Miller A (2002) Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg 12: 634–638PubMedCrossRef
34.
Zurück zum Zitat Schreiber H, Ben-Meir A, Sonpal I, Patterson L, Salomone M, Marshall JB (2005) Cigarette smoking, but not the presence of H. pylori, is associated with anastomotic ulcers in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis 1: 257CrossRef Schreiber H, Ben-Meir A, Sonpal I, Patterson L, Salomone M, Marshall JB (2005) Cigarette smoking, but not the presence of H. pylori, is associated with anastomotic ulcers in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis 1: 257CrossRef
35.
Zurück zum Zitat Smith DC, Herkes SB, Behrns KE (1993) Gastic acid secretion and vitamin B12 absorption after vertical Roux-en-y gastric bypass for morbid obesity. Ann Surg 218: 91–96PubMedCrossRef Smith DC, Herkes SB, Behrns KE (1993) Gastic acid secretion and vitamin B12 absorption after vertical Roux-en-y gastric bypass for morbid obesity. Ann Surg 218: 91–96PubMedCrossRef
36.
37.
Zurück zum Zitat Sugerman HJ, Kellum JM, Engle KM (1992) Gastric bypass for treating severe obesity. Am J Clin Nutr 55: 560–566 Sugerman HJ, Kellum JM, Engle KM (1992) Gastric bypass for treating severe obesity. Am J Clin Nutr 55: 560–566
38.
Zurück zum Zitat Wyatt HR (2003) The prevalence of obesity. Prim Care 30: 267–279PubMed Wyatt HR (2003) The prevalence of obesity. Prim Care 30: 267–279PubMed
39.
Zurück zum Zitat Zimmermann-Belsing T, Feldt-Rasmussen U (2004) Obesity, the new worldwide epidemic threat to general health and our complete lack of effective treatment. Endocrinology 145: 1501–1502PubMedCrossRef Zimmermann-Belsing T, Feldt-Rasmussen U (2004) Obesity, the new worldwide epidemic threat to general health and our complete lack of effective treatment. Endocrinology 145: 1501–1502PubMedCrossRef
Metadaten
Titel
Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients
verfasst von
J. J. Rasmussen
W. Fuller
M. R. Ali
Publikationsdatum
01.07.2007
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 7/2007
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-007-9285-x

Weitere Artikel der Ausgabe 7/2007

Surgical Endoscopy 7/2007 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.